IXICO

IXICO is a leading biotechnology research company dedicated to advancing medicine and human health by transforming data into clinically meaningful insights. With a focus on neuroimaging, IXICO helps biopharmaceutical companies maximize the value of their drug development pipelines. The company brings together world-class therapeutic expertise, breakthrough analytics, and operational excellence to provide imaging biomarker solutions for CNS clinical trials. IXICO's primary address is 15 Long Lane, London, EC1A 9PN, GB.

IXICO specializes in the end-to-end management and analysis of neuroimaging clinical trials, leveraging expertise and AI to deliver superior results. The company's comprehensive approach ensures that clients receive the highest quality data and insights, facilitating more informed decision-making throughout the drug development process. IXICO is committed to innovation and excellence in all aspects of its operations.

As a proven partner of choice, IXICO continues to set new standards in the field of neuroimaging. The company's dedication to advancing medicine and human health makes it a valuable asset to the biopharmaceutical industry. We invite the management of IXICO to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial development and reach.